Variable Interest Entity

6 Months Ended

Jun. 30, 2022

Variable Interest Entity, Measure of Activity [Abstract]

Variable Interest Entity

Variable Interest Entity

On July 15, 2021, we entered into an agreement whereby we obtained an 80.2% interest in DomaniRx, LLC (“DomaniRx”), a variable interest entity under GAAP. We have the power to direct the majority of the activities of DomaniRx that most significantly impact its economic performance, the obligation to absorb losses and the right to receive benefits from DomaniRx. Accordingly, we determined that we are the primary beneficiary of DomaniRx and consolidate its results.

The carrying value of the assets and liabilities associated with DomaniRx included in our condensed consolidated balance sheet as of June 30, 2022, which are limited for use in its operations and do not have recourse against our general credit or our senior secured credit facilities, are as follows:

	June 30,
	2022
Assets:
Cash and cash equivalents	$	148.3
Intangible assets		146.3
Other assets		0.1
Liabilities:
Other liabilities		8.1